Short Interest in Ainos, Inc. (NASDAQ:AIMD) Grows By 58.1%

Ainos, Inc. (NASDAQ:AIMD) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 255,800 shares, a growth of 58.1% from the November 30th total of 161,800 shares. Based on an average daily trading volume, of 374,300 shares, the short-interest ratio is presently 0.7 days. Approximately 6.1% of the company’s shares are short sold.

Ainos Stock Performance

Shares of AIMD stock opened at $0.45 on Friday. The company’s fifty day simple moving average is $0.47 and its 200-day simple moving average is $0.59. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.37 and a quick ratio of 1.33. Ainos has a 52 week low of $0.40 and a 52 week high of $4.29.

Ainos (NASDAQ:AIMD) last announced its earnings results on Wednesday, November 6th. The company reported ($0.33) earnings per share for the quarter. Ainos had a negative net margin of 15,348.14% and a negative return on equity of 75.16%.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.